The methanolic fraction
(M-F) of the total extract (TE)
of Plumeria obtusa L. aerial parts
showed promising
antibacterial effects against the MDR (multidrug-resistant) gram-negative
pathogens Klebsiella pneumoniae and Escherichia coli O157:H7 [Shiga toxin-producing E. coli (STEC)]. In addition, M-F had a synergistic
effect (in combination with vancomycin) against the MDR gram-positive
strains MRSA (methicillin-resistant Staphylococcus
aureus) and Bacillus cereus. After treating the K. pneumoniae- and STEC-infected mice with M-F (25 mg/kg, i.p.), the level of
IgM and TNF-α was decreased and the severity of pathological
lesions were reduced better than that observed after administration
of gentamycin (33 mg/kg, i.p.). Thirty-seven compounds including 10
plumeria-type iridoids and 18 phenolics, 7 quinoline derivatives,
1 amino acid, and 1 fatty acid were identified in TE using LC/ESI-QToF.
Furthermore, five compounds; kaempferol 3-O-rutinoside
(M1), quercetin 3-O-rutinoside (M2), glochiflavanoside B (M3), plumieride (M4), and 13-O-caffeoylplumieride (M5) were isolated from M-F. M5 was active against K. pneumoniae (MIC of 64 μg/mL) and STEC (MIC
of 32 μg/mL). These findings suggested that M-F and M5 are promising antimicrobial natural products for combating MDR K. pneumoniae and STEC nosocomial infections.